Pharmacogenomics: Genetic variation as a guide to drug development

被引：0
|
作者：
Kleyne, P [1 ]
机构：
[1] Millennium Pharmaceut, Cambridge, MA USA
来源：
BIOLOGICAL PSYCHIATRY | 1999年 / 45卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
161
引用
收藏
页码：50S / 50S
页数：1
相关论文
共 50 条
  • [1] Genetic variation as a guide to drug development
    Kleyn, PW
    Vesell, ES
    [J]. SCIENCE, 1998, 281 (5384) : 1820 - 1821
  • [2] Pharmacogenomics: A Genetic Approach to Drug Development and Therapy
    Qahwaji, Rowaid
    Ashankyty, Ibraheem
    Sannan, Naif S.
    Hazzazi, Mohannad S.
    Basabrain, Ammar A.
    Mobashir, Mohammad
    [J]. PHARMACEUTICALS, 2024, 17 (07)
  • [3] Pharmacogenomics and variation in drug therapy
    Wong, SHY
    [J]. 2005 EMERGING INFORMATION TECHNOLOGY CONFERENCE (EITC), 2005, : 52 - 54
  • [4] Genetic variation in drug development
    [J]. Nature Biotechnology, 1998, 16 (Suppl 2) : 16 - 19
  • [5] Pharmacogenomics in drug development
    Salerno, RA
    [J]. GENETIC ENGINEERING NEWS, 2005, 25 (12): : 14 - 14
  • [6] Pharmacogenomics and Drug Development
    Murphy, Michael F.
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2010, 3 (02): : 79 - 80
  • [7] Pharmacogenomics and drug development
    Guo, YY
    Shafer, S
    Weller, P
    Usuka, J
    Peltz, G
    [J]. PHARMACOGENOMICS, 2005, 6 (08) : 857 - 864
  • [8] Pediatric Pharmacogenomics A Systematic Assessment of Ontogeny and Genetic Variation to Guide the Design of Statin Studies in Children
    Wagner, Jonathan
    Leeder, J. Steven
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2012, 59 (05) : 1017 - +
  • [9] Integrating pharmacogenomics into drug development
    Ferentz, AE
    [J]. PHARMACOGENOMICS, 2002, 3 (04) : 453 - 467
  • [10] Implications of Pharmacogenomics for Drug Development
    Kirk, Randal J.
    Hung, Jeffrey L.
    Horner, Scorr R.
    Perez, Jeffrey T.
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 233 (12) : 1484 - 1497
12345